Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Retrophin Inc (NASDAQ:RTRX)

14.93
Delayed Data
As of Feb 05
 -0.83 / -5.27%
Today’s Change
12.75
Today|||52-Week Range
37.04
-22.60%
Year-to-Date

Today’s Trading

Previous close15.76
Today’s open15.62
Day’s range14.84 - 15.80
Volume676,027
Average volume (3 months)592,076
Market cap$539.7M
Dividend yield--
Data as of 4:00pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)-86.13%
Earnings growth (this year)+263.98%
Earnings growth (next 5 years)+8.00%
Revenue growth (last year)--
P/E ratio5.6
Price/Sales10.87
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CHRSCoherus BioSciences ...+1.09+8.23%
FMIFoundation Medicine ...-0.39-2.55%
ADAPAdaptimmune Therapeu...-0.43-5.70%
ATRAAtara Biotherapeutic...-1.68-8.92%
Data as of 4:00pm ET, 02/05/2016

Financials

Next reporting dateMarch 24, 2016
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$28.2M
Annual profit (last year)-$110.9M
Net profit margin-393.35%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Stephen J. Aselage
Chief Financial Officer &
Senior Vice President
Laura M. Clague
Corporate headquarters
San Diego, California

Forecasts

Partner Offers